These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 1947955

  • 1. [Comparison of the effect of 5-hydroxytryptophan and propranolol in the interval treatment of migraine].
    Maissen CP, Ludin HP.
    Schweiz Med Wochenschr; 1991 Oct 26; 121(43):1585-90. PubMed ID: 1947955
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the efficacy and safety of flunarizine to propranolol in the prophylaxis of migraine.
    Gawel MJ, Kreeft J, Nelson RF, Simard D, Arnott WS.
    Can J Neurol Sci; 1992 Aug 26; 19(3):340-5. PubMed ID: 1393843
    [Abstract] [Full Text] [Related]

  • 3. [The treatment of juvenile migraine using flunarizine or propranolol].
    Lütschg J, Vassella F.
    Schweiz Med Wochenschr; 1990 Nov 17; 120(46):1731-6. PubMed ID: 2251492
    [Abstract] [Full Text] [Related]

  • 4. A double blind controlled study of propranolol and cyproheptadine in migraine prophylaxis.
    Rao BS, Das DG, Taraknath VR, Sarma Y.
    Neurol India; 2000 Sep 17; 48(3):223-6. PubMed ID: 11025624
    [Abstract] [Full Text] [Related]

  • 5. [Beta-blockers and migraine. Efficacy of time-release propranolol versus placebo].
    Pradalier A, Serratrice G, Collard M, Hirsch E, Feve J, Masson M, Masson C, Dry J, Koulikovsky G, Nguyen G.
    Therapie; 1990 Sep 17; 45(5):441-5. PubMed ID: 2260046
    [Abstract] [Full Text] [Related]

  • 6. Cyclandelate versus propranolol in the prophylaxis of migraine--a double-blind placebo-controlled study.
    Gerber WD, Schellenberg R, Thom M, Haufe C, Bölsche F, Wedekind W, Niederberger U, Soyka D.
    Funct Neurol; 1995 Sep 17; 10(1):27-35. PubMed ID: 7649498
    [Abstract] [Full Text] [Related]

  • 7. Treatment of migraine with propranolol.
    Borgesen SE.
    Postgrad Med J; 1976 Sep 17; 52 Suppl 4():163-5. PubMed ID: 787958
    [Abstract] [Full Text] [Related]

  • 8. [Treatment of migraine attacks: combination of dihydroergotamine tartrate and paracetamol in comparison with individual drugs and placebo].
    Hoernecke R, Doenicke A.
    Med Klin (Munich); 1993 Nov 15; 88(11):642-8. PubMed ID: 8295604
    [Abstract] [Full Text] [Related]

  • 9. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun 15; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.
    Cady RK, Mathew N, Diener HC, Hu P, Haas M, Novak GP, Study Group.
    Headache; 2009 Feb 15; 49(2):216-26. PubMed ID: 19222595
    [Abstract] [Full Text] [Related]

  • 11. Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine.
    Stensrud P, Sjaastad O.
    Ups J Med Sci Suppl; 1980 Feb 15; 31():37-40. PubMed ID: 7006182
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Propranolol in the treatment of migraine.
    Behan PO, Reid M.
    Practitioner; 1980 Feb 15; 224(1340):201-3. PubMed ID: 6988825
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment?
    Schellenberg R, Lichtenthal A, Wöhling H, Graf C, Brixius K.
    Headache; 2008 Jan 15; 48(1):118-25. PubMed ID: 18184294
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of low-intensity acenocoumarol on frequency and severity of migraine attacks.
    Wammes-van der Heijden EA, Smidt MH, Tijssen CC, van't Hoff AR, Lenderink AW, Egberts AC.
    Headache; 2005 Feb 15; 45(2):137-43. PubMed ID: 15705119
    [Abstract] [Full Text] [Related]

  • 19. Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis.
    Goadsby PJ, Ferrari MD, Csanyi A, Olesen J, Mills JG, Tonabersat TON-01-05 Study Group.
    Cephalalgia; 2009 Jul 15; 29(7):742-50. PubMed ID: 19222510
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.